Arkolith/Insider Trading/SRPT/Form 4

Behrens M Kathleen

DirectorSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Jan 29, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)11K$13.71$144K204K
Jan 27, 2026Tax withholding(F)6K$22.17$144K197K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)11K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-029893) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML